Systems Bioinformatic Approach to Determine the Pharmacological Mechanisms of Radix Astragali and Radix Angelicae sinensis in Idiopathic Pulmonary Fibrosis
Yufeng Zhang2,3,4, Lina Gu2,4, Juan PuYang4, Mengying Liu5, Qingqing Xia3, Weilong Jiang3★, Mengshu Cao2,4,5★ Corresponding author
- 1Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- 2Department of Respiratory Medicine, Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangyin, China.
- 3Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, China.
- 4Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
CORRESPONDENCE
Weilong Jiang
Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, China.
Received: 07-01-2021; Revised: 10-04-2021; Accepted: 06-05-2021.
Volume 17, Issue 76 · pp. 708–718 · PUBLISHED 24 January 2022 · DOI: 10.4103/pm.pm_9_21
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Objectives: The objective of the study was to regulate the pharmacological mechanism of RA and RAS in IPF treatment. Materials and Methods: Microarray datasets for IPF were examined in the Gene Expression Omnibus database and differentially expressed genes (DEGs) were recognized. Active compounds and target genes of RA and RAS were recognized using the Traditional Chinese Medicine Systems Pharmacology platform. The DEGs were combined with the active target genes to construct a medicine‑compound‑gene network and a protein–protein interaction network using Cytoscape software. Gene ontology function enrichment and Kyoto Encyclopedia of Genes and Genomes pathway enrichment were studied using RGUI. A gene‑pathway network was established using Cytoscape and molecular docking was done using AutoDock Tool and AutoDock Vina software. Results: We recognized 1566 DEGs and 40 candidate target genes of RA and RAS acting on IPF. The six key active compounds prophesied were quercetin, kaempferol, stigmasterol, 7‑O‑methylisomucronulatol, formononetin, and beta‑sitosterol. Following network construction and enrichment, the two main pathways were acknowledged, namely the tumor necrosis factor signaling pathway and advanced glycation end (AGE) products receptor for AGE signaling pathway. Preliminary molecular docking to confirm interactions between key compounds and their protein targets in the pathways was carried out. Conclusion: The pharmacological mechanisms of RA and RAS in IPF treatment have been further elucidated, which could show valuable in future studies on their mechanisms of action for the treatment of IPF.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Zhang, Y., Gu, L., PuYang, J., Liu, M., Xia, Q., Jiang, W., & Cao, M. (2022). Systems Bioinformatic Approach to Determine the Pharmacological Mechanisms of Radix Astragali and Radix Angelicae sinensis in Idiopathic Pulmonary Fibrosis. Pharmacognosy Magazine, 17(76), 708–718. https://doi.org/10.4103/pm.pm_9_21
